NanoImaging Services has opened what it claims is a first of its kind fee-for-service imaging business to enable structural characterisation and validation of biological drugs throughout the development pipeline. New Service Offers High-Resolution 3D TEM Imaging of Large Biological Molecules
Nanotherapeutics, has been awarded a $20 Million 4-year contract from the National Institute of Allergy and Infectious Diseases (NIAID) to develop an inhaled version of the injectable drug, gentamicin.
Pharmaceutical companies are facing expiration of the patent protection on their main profit generators and having relatively fewer new products in the pipeline. Nanomedicine holds the key for future